Fulvio Alexandre Scorza Selected Research

Pilocarpine (Ocusert)

6/2021	Effects of fish oil supplementation on spatial memory in rats with pilocarpine-induced epilepsy assessed using the Morris Water Maze test.
11/2018	Long-term monotherapy treatment with vitamin E reduces oxidative stress, but not seizure frequency in rats submitted to the pilocarpine model of epilepsy.
3/2015	Early life seizures in female rats lead to anxiety-related behavior and abnormal social behavior characterized by reduced motivation to novelty and deficit in social discrimination.
7/2013	Activation and involvement of the lateral-posterior nucleus of the thalamus after a single generalized tonic-clonic seizure.
6/2012	Social behavior impairment in offspring exposed to maternal seizures in utero.
12/2011	Early physical exercise and seizure susceptibility later in life.
7/2010	Favorable effects of physical activity for recovery in temporal lobe epilepsy.
12/2008	Neurogenesis induced by seizures in the dentate gyrus is not related to mossy fiber sprouting but is age dependent in developing rats.
12/2008	Serotonin depletion effects on the pilocarpine model of epilepsy.
9/2008	Myocyte-specific enhancer binding factor 2C (MEF2C) expression in the dentate gyrus during development and after pilocarpine-induced status epilepticus: a preliminary report.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fulvio Alexandre Scorza Research Topics

Disease

27	Epilepsy (Aura) 06/2021 - 06/2002
14	Seizures (Absence Seizure) 01/2022 - 09/2002
10	Status Epilepticus (Complex Partial Status Epilepticus) 03/2015 - 06/2002
5	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2018
4	Sudden Unexpected Death in Epilepsy 01/2022 - 06/2007
3	Temporal Lobe Epilepsy 01/2021 - 07/2008
2	Pain (Aches) 10/2018 - 10/2010
2	Chronic Renal Insufficiency 07/2013 - 09/2005
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 02/2022
1	Guillain-Barre Syndrome 10/2021
1	COVID-19 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Hypertrophy 01/2021
1	Rhabdomyolysis 01/2021
1	Sleep Wake Disorders 10/2018
1	Migraine Disorders (Migraine) 10/2018
1	Heart Failure 01/2018
1	Sudden Death 01/2018
1	Schizophrenia (Dementia Praecox) 01/2018
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Cardiovascular Abnormalities 07/2013
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 07/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013
1	Drug Resistant Epilepsy 12/2012
1	Hyperthermia 01/2011
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2005

Drug/Important Bio-Agent (IBA)

20	Pilocarpine (Ocusert)FDA LinkGeneric 06/2021 - 06/2002
3	salicylhydroxamic acid (SHAM)IBA 01/2022 - 11/2012
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 06/2007
2	SteroidsIBA 02/2022 - 10/2021
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022 - 07/2013
2	Fish OilsIBA 06/2021 - 01/2017
2	ParvalbuminsIBA 11/2018 - 05/2007
2	Lovastatin (Mevacor)FDA LinkGeneric 01/2011 - 12/2005
2	Glucose (Dextrose)FDA LinkGeneric 09/2003 - 06/2002
1	Immunoglobulins (Immunoglobulin)IBA 10/2021
1	AntibodiesIBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Domperidone (Domperidon)IBA 10/2020
1	Vitamin D FDA LinkGeneric 04/2020
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2019
1	Vitamin E FDA LinkGeneric 11/2018
1	Type A Botulinum Toxins (Botox)FDA Link 10/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Biological ProductsIBA 03/2015
1	CationsIBA 10/2013
1	SymportersIBA 10/2013
1	ChloridesIBA 10/2013
1	Kainic Acid (Kainate)IBA 01/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2011
1	NeurosteroidsIBA 12/2010
1	Opioid Peptides (Opioid Peptide)IBA 10/2010
1	beta-Endorphin (Endorphin, beta)IBA 10/2010
1	NestinIBA 09/2009
1	SolutionsIBA 12/2008
1	5,7-Dihydroxytryptamine (5,7 Dihydroxytryptamine)IBA 12/2008
1	Serotonin (5 Hydroxytryptamine)IBA 12/2008
1	Pharmaceutical PreparationsIBA 12/2008
1	MEF2 Transcription FactorsIBA 09/2008
1	Calcitriol Receptors (Calcitriol Receptor)IBA 07/2008
1	Messenger RNA (mRNA)IBA 07/2008
1	MelatoninIBA 01/2006
1	amsonic acid (DAS)IBA 09/2005
1	BicucullineIBA 10/2004
1	PotassiumIBA 10/2004
1	Deoxyglucose (2 Deoxy D glucose)IBA 09/2003

Therapy/Procedure

5	Therapeutics 03/2013 - 09/2005
2	Complementary Therapies (Alternative Medicine) 01/2018 - 03/2013
2	Renal Dialysis (Hemodialysis) 07/2013 - 09/2005
1	Plasma Exchange 10/2021
1	Self Medication 10/2018
1	Low-Level Light Therapy (LLLT) 10/2018
1	Vagus Nerve Stimulation 12/2012
1	Resistance Training 11/2012
1	Investigational Therapies (Experimental Therapy) 01/2006